Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 19 results.
User Information
Export Records
  1. 1.   Systemic inflammatory Th1 cytokines during Trypanosoma cruzi infection disrupt the typical anatomical cell distribution and phenotypic/functional characteristics of various cell subsets within the thymus
  2. Viano, Estefania; Baez, Natalia S; Savid-Frontera, Constanza; Baigorrí, Eliana; Dinatale, Brenda; Pacini, Maria Florencia; Bulfoni Balbi, Camila; Gonzalez, Florencia Belén; Fozzatti, Laura; Lidón, Nicolas L; Young,Howard; Hodge, Deborah; Cerban, Fabio; Stempin, Cinthia; Pérez, Ana Rosa; Rodriguez Galán, Maria Cecilia
  3. Microbes and Infection. 2024, Apr 12; 105337.
  1. 2.   Commensal-specific T cell plasticity promotes rapid tissue adaptation to injury
  2. Harrison, Oliver J.; Linehan, Jonathan L.; Shih, Han-Yu; Bouladoux, Nicolas; Han, Seong-Ji; Smelkinson, Margery; Sen, Shurjo; Byrd, Allyson L.; Enamorado, Michel; Yao, Chen; Tamoutounour, Samira; Van Laethem, Francois; Hurabielle, Charlotte; Collins, Nicholas; Paun, Andrea; Salcedo, Rosalba; O'Shea, John J.; Belkaid, Yasmine
  3. Science (New York, N.Y.). 2019, Jan 4; 363(6422): 43-+.
  1. 3.   Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance
  2. An, P.; Thio, C. L.; Kirk, G. D.; Donfield, S.; Goedert, J. J.; Winkler, C. A.
  3. Journal of Infectious Diseases. 2008 198(8): 1159-1165.
  1. 4.   Cytokines in pulmonary emphysema: Can results in mice be translated to humans?
  2. Hoshino, T.; Young, H. A.; Aizawa, H.
  3. American Journal of Respiratory and Critical Care Medicine. 2008 177(2): 238-239.
  1. 5.   Pulmonary inflammation and emphysema - Role of the Cytokines IL-18 and IL-13
  2. Hoshino, T.; Kato, S.; Oka, N.; Imaoka, H.; Kinoshita, T.; Takei, S.; Kitasato, Y.; Kawayama, T.; Imaizumi, T.; Yamada, K.; Young, H. A.; Aizawa, H.
  3. American Journal of Respiratory and Critical Care Medicine. 2007, Jul; 176(1): 49-62.
  1. 6.   Regulation of ITAM-positive receptors: role of IL-12 and IL-18
  2. Ortaldo, J. R.; Winkler-Pickett, R.; Wigginton, J.; Horner, M.; Bere, E. W.; Mason, A. T.; Bhat, N.; Cherry, J.; Sanford, M.; Hodge, D. L.; Young, H. A.
  3. Blood. 2006, FEB 15; 107(4): 1468-1475.
  1. 7.   Cytokines as critical co-stimulatory molecules in modulating the immune response of natural killer cells
  2. Young, H. A.; Ortaldo, J.
  3. Cell Research. 2006, Jan; 16(1): 20-24.
  1. 8.   Toxicity vs antitumor effects of hydrodynamic IL-12 (interleukin-12) and IL-18 cDNA injections
  2. Rodriguez-Galan, M. C.; Watanabe, M.; Young, H. A.
  3. Faseb Journal. 2005, MAR 7; 19(5, Part 2, Suppl. S): A1406-A1406.
  1. 9.   Synergistic effect of IL-2, IL-12, and IL-18 on thymocyte apoptosis and Th1/Th2 cytokine expression
  2. Rodriguez-Galan, M. C.; Bream, J. H.; Farr, A.; Young, H. A.
  3. Journal of Immunology. 2005, MAR 1; 174(5): 2796-2804.
  1. 10.   Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization
  2. Mohamadzadeh, M.; Olson, S.; Kalina, W. V.; Ruthel, G.; Demmin, G. L.; Warfield, K. L.; Bavari, S.; Klaenhammer, T. R.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2005, FEB 22; 102(8): 2880-2885.
  1. 11.   Tumor cell IFN-gamma responsiveness mediates the generation of tumor-specific immunologic reactivity and overall antitumor activity of IL-18 in mice bearing neuroblastoma tumors
  2. Hixon, J.; Stauffer, J. K.; Khan, T.; Salcedo, R.; Lincoln, E.; Back, T. C.; Jonak, Z.; Dar, M.; Wigginton, J. M.
  3. Journal of Immunotherapy. 2005, NOV-DEC; 28(6): 627-627.
  1. 12.   IL-18 plus IL-12 decreases liver metastases through An NK cell, IFN-gamma dependent mechanism and overcomes NK/T cell mediated suppression
  2. Subleski, A.; Back, T. C.; Ortaldo, J. R.; Wiltrout, R. H.
  3. Journal of Immunotherapy. 2005, NOV-DEC; 28(6): 626-626.
  1. 13.   NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer
  2. Smyth, M. J.; Swann, J.; Kelly, J. M.; Cretney, E.; Yokoyama, W. M.; Diefenbach, A.; Sayers, T. J.; Hayakawa, Y.
  3. Journal of Experimental Medicine. 2004, NOV 15; 200(10): 1325-1335.
  1. 14.   IL-18 induces complete regression of orthotopic primary and metastatic murine neuroblastoma tumors and potentiates antitumor immune reactivity in combination with IL-2
  2. Hixon, J.; Stauffer, J.; Lincoln, E.; Back, T.; Jonak, Z.; Wigginton, J.
  3. Journal of Immunotherapy. 2004, NOV-DEC; 27(6): S17-S18.
  1. 15.   Toxicity vs. antitumor activity of IL-12 and IL-18 cDNA injections in C57BL/6 mice
  2. Rodriguez-Galan, M. C.; Watanabe, M.; Young, H. A.
  3. Journal of Leukocyte Biology. 2004 (Suppl. S): 56-56.
  1. 16.   Redox-active protein thioredoxin prevents proinflammatory cytokine- or bleomycin-induced lung injury
  2. Hoshino, T.; Nakamura, H.; Okamoto, M.; Kato, S.; Araya, S.; Nomiyama, K.; Oizumi, K.; Young, H. A.; Aizawa, H.; Yodoi, J.
  3. American Journal of Respiratory and Critical Care Medicine. 2003 168(9): 1075-1083.
  1. 17.   Synergistic engagement of an ineffective endogenous anti-tumor immune response and induction of IFN-gamma and Fas-ligand- dependent tumor eradication by combined administration of IL-18 and IL-2
  2. Wigginton, J. M.; Lee, J. K.; Wiltrout, T. A.; Alvord, W. G.; Hixon, J. A.; Subleski, J.; Back, T. C.; Wiltrout, R. H.
  3. Journal of Immunology. 2002 169(8): 4467-4474.
  1. 18.   In vivo administration of IL-18 can induce IgE production through Th2 cytokine induction and up-regulation of CD40 ligand (CD154) expression on CD4(+) T cells
  2. Hoshino, T.; Yagita, H.; Ortaldo, J. R.; Wiltrout, R. H.; Young, H. A.
  3. European Journal of Immunology. 2000 30(7): 1998-2006.
  1. 19.   Exploring the immunomodulatory role of virtual memory CD8+ T cells: Role of IFN gamma in tumor growth control
  2. Savid-Frontera, Constanza; Viano, Maria Estefania; Baez, Natalia S; Lidon, Nicolas L; Fontaine, Quentin; Young,Howard; Vimeux, Lene; Donnadieu, Emmanuel; Rodriguez-Galan, Maria Cecilia
  3. Frontiers in Immunology. 2022 13: 971001.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel